Brevan Howard Capital Management’s Exelixis EXEL Stock Holding History

Brevan Howard Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86M	Buy	52,608 +46,721	+794%	+$2.27M	0.02%	575
2026 Q1	$252K	Sell	5,887 -14,947	-72%	-$643K	﹤0.01%	1745
2025 Q4	$913K	Buy	20,834 +3,952	+23%	+$163K	0.01%	809
2025 Q3	$697K	Sell	16,882 -50,066	-75%	-$2.01M	﹤0.01%	1105
2025 Q2	$2.95M	Buy	+66,948	New	+$2.68M	0.02%	581
2025 Q1	–	Sell	-27,945	Closed	-$931K	–	1253
2024 Q4	$931K	Sell	27,945 -20,941	-43%	-$679K	0.01%	453
2024 Q3	$1.27M	Sell	48,886 -18,855	-28%	-$469K	0.01%	383
2024 Q2	$1.52M	Buy	67,741 +26,185	+63%	+$581K	0.01%	256
2024 Q1	$986K	Buy	41,556 +32,134	+341%	+$714K	0.01%	273
2023 Q4	$226K	Buy	+9,422	New	+$205K	﹤0.01%	838

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's EXEL Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Exelixis (EXEL) stake by 794% in Q2 2026, buying an estimated $2.27M and bringing the position to 52,608 shares worth $2.86M. The position accounts for 0.02% of the portfolio, ranked #575.

Brevan Howard Capital Management first reported a position in EXEL in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.95M in Q2 2025. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Brevan Howard Capital Management held 52,608 shares of Exelixis worth $2.86M as of Q2 2026.
Brevan Howard Capital Management bought 46,721 Exelixis shares in Q2 2026, an estimated $2.27M.
Exelixis made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #575 holding.
Brevan Howard Capital Management first reported a position in Exelixis in Q4 2023 and has held it in 10 quarters since.
Brevan Howard Capital Management's Exelixis position peaked at $2.95M in Q2 2025.
756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.